MedTrace Logo

Prognostic Significance of Mutation Type and Chromosome Fragility in Fanconi Anemia

NCT06490510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2024-07-08

No results posted yet for this study

Summary

The goal of this observational study is to analyze the data included in the Spanish Registry of Patients with Fanconi anemia to better understand the natural history of the disease, identify genetic risk and prognostic factors, and identify potential therapeutic strategies.

Conditions

  • Fanconi Anemia

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Jordi Surrallés, PhD · Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-16
Primary Completion
2024-06-18
Completion
2024-06-18

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06490510 on ClinicalTrials.gov